• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
ReportsnReports – Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018
 

ReportsnReports – Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018

on

  • 588 views

GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source ...

GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Atopic Dermatitis Therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market.

Statistics

Views

Total Views
588
Views on SlideShare
588
Embed Views
0

Actions

Likes
0
Downloads
3
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    ReportsnReports – Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018 ReportsnReports – Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018 Document Transcript

    • Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to2018ReportsnReports.com adds GlobalData Market Research Report “Atopic DermatitisTherapeutics – Pipeline Assessment and Market Forecasts to 2018’’ to its store.GlobalData, the industry analysis specialist, has released its new report, “Atopic DermatitisTherapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is anessential source of information and analysis on the global Atopic Dermatitis Therapeuticsmarket. The report identifies the key trends shaping and driving the global Atopic DermatitisTherapeutics market. The report also provides insights on the prevalent competitive landscape and the emergingplayers expected to significantly alter the market positioning of the current market leaders.Most importantly, the report provides valuable insights on the pipeline products within theglobal Atopic Dermatitis Therapeutics sector. This report is built using data and informationsourced from proprietary databases, primary and secondary research and in-house analysisby GlobalData’s team of industry experts.ScopeThe report provides information on the key drivers and challenges of the Atopic DermatitisTherapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017. Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. Analysis of the current and future competition in the seven key countries Atopic Dermatitis Therapeutics market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Atopic Dermatitis Therapeutics market. Analysis of key recent licensing and partnership agreements in Atopic Dermatitis Therapeutics marketReasons to buyThe report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. Develop business strategies by understanding the trends shaping and driving the global Atopic Dermatitis Therapeutics market.
    •  Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Atopic Dermatitis Therapeutics market in future. Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. What’s the next big thing in the global Atopic Dermatitis Therapeutics market landscape? – Identify, understand and capitalize.Table of contents1 Table of contents1.1 List of Tables1.2 List of Figures2 Atopic Dermatitis – Introduction2.1 Overview2.2 Epidemiology2.3 Etiology2.4 Symptoms2.5 Diagnosis2.6 Pathophysiology2.7 Treatment and Management Pattern2.8 GlobalData Pipeline Report Guidance3 Atopic DermatitisTherapeutics – Market Characterization3.1 Atopic Dermatitis Market Size (2005 – 2010) – Global3.2 Atopic Dermatitis Market Forecast (2010 – 2018) – Global3.3 Atopic Dermatitis Market Size (2005 – 2010) – The US3.4 Atopic Dermatitis Market Forecast (2010 – 2018) – The US3.5 Atopic Dermatitis Market Size (2005 – 2010) – France3.6 Atopic Dermatitis Market Forecast (2010 – 2018) – France3.7 Atopic Dermatitis Market Size (2005 – 2010) – Germany3.8 Atopic Dermatitis Market Forecast (2010 – 2018) – Germany3.9 Atopic Dermatitis Market Size (2005 – 2010) – Italy3.10 Atopic Dermatitis Market Forecast (2010 – 2018) – Italy3.11 Atopic Dermatitis Market Size (2005 – 2010) – Spain3.12 Atopic Dermatitis Market Forecast (2010 – 2018) – Spain3.13 Atopic Dermatitis Market Size (2005 – 2010) – The UK3.14 Atopic Dermatitis Market Forecast (2010 – 2018) – The UK3.15 Atopic Dermatitis Market Size (2005 – 2010) – Japan3.16 Atopic Dermatitis Market Forecast (2010 – 2018) – Japan3.17 Drivers and Barriers for the Atopic Dermatitis Market3.17.1 Drivers for the Atopic Dermatitis Market3.17.2 Barriers for the Atopic Dermatitis Market
    • 3.18 Opportunity and Unmet Need3.19 Key Takeaway4 Atopic Dermatitis Market – Competitive Assessment4.1 Overview4.2 Strategic Competitor Assessment4.3 Product Profile for Major Marketed Products in the Atopic Dermatitis Market4.3.1 Protopic (tacrolimus)4.3.2 Elidel (pimecrolimus)4.3.3 MimyX4.3.4 Atopiclair4.3.5 Topical Corticosteroids4.4 Key Takeaway5 Atopic Dermatitis – Pipeline Assessment5.1 Overview5.2 Strategic Pipeline Assessment5.3 Atopic Dermatitis – Pipeline Analysis by Phase of Development5.3.1 Atopic Dermatitis – Filed and Phase III Pipeline5.3.2 Atopic Dermatitis – Phase II Pipeline5.3.3 Atopic Dermatitis – Phase I Pipeline5.3.4 Atopic Dermatitis – Preclinical Pipeline5.4 Atopic Dermatitis – Pipeline by Mechanism of Action5.5 Technology Trends Analytical Framework5.6 Most Promising Drug Profiles5.6.1 LAS 410025.7 Key Takeaway6 Atopic Dermatitis – Clinical Trials Mapping6.1 Clinical Trials by Region and Country6.2 Clinical Trials by Phase of Clinical Development6.3 Clinical Trials by Trial Status6.4 Clinical Trials by Sponsors6.5 Top Companies Participating in Atopic Dermatitis Clinical Trials7 Atopic Dermatitis Market – Strategic Assessment7.1 Key Events Impacting the Future Market7.2 Future Market Competition Scenario8 Atopic Dermatitis Market – Future Companies8.1 Introduction8.2 Company Profiles8.2.1 Almirall8.2.2 Anacor Pharmaceuticals8.2.3 BioCis Pharmaceuticals8.2.4 MIKA Pharma GmbH8.3 Details of Other Companies in the Pipeline8.4 Key Takeaway
    • 9 Atopic Dermatitis – Licensing and Partnership Deals10 Atopic Dermatitis – Appendix10.1 Definitions10.2 Acronyms10.3 Methodology10.3.1 Coverage10.3.2 Secondary Research10.3.3 Forecasting10.3.4 Primary Research10.3.5 Expert Panel Validation10.4 Contact Us10.5 Disclaimer10.6 BibliographyList of TablesTable 1: Atopic Dermatitis Therapeutics – Treatment OptionsTable 2: Atopic Dermatitis Therapeutics – Commonly Used Topical CorticosteroidsTable 3: Atopic Dermatitis Market, Global, Revenue ($m), 2005 – 2010Table 4: Atopic Dermatitis Market, Global, Forecast ($m), 2010 – 2018Table 5: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 – 2010Table 6: Atopic Dermatitis Market, The US, Forecast ($m), 2010 – 2018Table 7: Atopic Dermatitis Market, France, Revenue ($m), 2005 – 2010Table 8: Atopic Dermatitis Market, France, Forecast ($m), 2010 – 2018Table 9: Atopic Dermatitis Market, Germany, Revenue ($m), 2005 – 2010Table 10: Atopic Dermatitis Market, Germany, Forecast ($m), 2010 – 2018Table 11: Atopic Dermatitis Market, Italy, Revenue ($m), 2005 – 2010Table 12: Atopic Dermatitis Market, Italy, Forecast ($m), 2010 – 2018Table 13: Atopic Dermatitis Market, Spain, Revenue ($m), 2005 – 2010Table 14: Atopic Dermatitis Market, Spain, Forecast ($m), 2010 – 2018Table 15: Atopic Dermatitis Market, The UK, Revenue ($m), 2005 – 2010Table 16: Atopic Dermatitis Market, The UK, Forecast ($m), 2010 – 2018Table 17: Atopic Dermatitis Market, Japan, Revenue ($m), 2005 – 2010Table 18: Atopic Dermatitis Market, Japan, Forecast ($m), 2010 – 2018Table 19: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacyof Protopic in Phase III Clinical Trials, 2003Table 20: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacyof Elidel in Clinical Trials, 1998 – 2002Table 21: Atopic Dermatitis Therapeutics Market, Global, Major Marketed ProductsComparison, 2011Table 22: Atopic Dermatitis Therapeutics – Phase III Clinical Pipeline, 2011Table 23: Atopic Dermatitis Therapeutics – Phase II Clinical Pipeline, 2011Table 24: Atopic Dermatitis Therapeutics – Phase I Clinical Pipeline, 2011Table 25: Atopic Dermatitis Therapeutics – Pre-Clinical and Discovery Pipeline, 2011Table 26: LAS 41002 – Clinical Study DetailsTable 27: Atopic Dermatitis, Global, Clinical Trials, 2011Table 28: Atopic Dermatitis, Global, Clinical Trials by Phase, 2011Table 29: Atopic Dermatitis, Global, Clinical Trials by Status of Development, 2011Table 30: Atopic Dermatitis, Global, Overall Sponsors, 2011
    • Table 31: Atopic Dermatitis, Global, Prominent Sponsors, 2011Table 32: Atopic Dermatitis, Global, Top Ten Companies by Phase, 2011Table 33: Almirall – Dermatology Pipeline Products, 2011Table 34: Anacor Pharmaceuticals – Dermatology Pipeline Products, 2011Table 35: BioCis Pharmaceuticals – Dermatology Pipeline Products, 2011Table 36: MIKA Pharma GmbH – Dermatology Pipeline Products, 2011Table 37: Description of Other Companies in the Pipeline, 2011Table 38: Atopic Dermatitis, Global, Deals, 2011List of FiguresFigure 1: Atopic Dermatitis Therapeutics – Eczematous SkinFigure 2: Atopic Dermatitis – Causes of Atopic DermatitisFigure 3: Atopic Dermatitis – Sign and SymptomsFigure 4: Atopic Dermatitis – PathophysiologyFigure 5: Atopic Dermatitis – Treatment AlgorithmFigure 6: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2005 – 2010Figure 7: Atopic Dermatitis Therapeutics Market, Global, Forecast ($m), 2010 – 2018Figure 8: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 – 2010Figure 9: Atopic Dermatitis Therapeutics Market, The US, Forecast ($m), 2010 – 2018Figure 10: Atopic Dermatitis Therapeutics Market, France, Revenue ($m), 2005 – 2010Figure 11: Atopic Dermatitis Therapeutics Market, France, Forecast ($m), 2010 – 2018Figure 12: Atopic Dermatitis Therapeutics Market, Germany , Revenue ($m), 2005 – 2010Figure 13: Atopic Dermatitis Therapeutics Market, Germany, Forecast ($m), 2010 – 2018Figure 14: Atopic Dermatitis Therapeutics Market, Italy, Revenue ($m), 2005 – 2010Figure 15: Atopic Dermatitis Therapeutics Market, Italy, Forecast ($m), 2010 – 2018Figure 16: Atopic Dermatitis Therapeutics Market, Spain, Revenue ($m), 2005 – 2010Figure 17: Atopic Dermatitis Therapeutics Market, Spain, Forecast ($m), 2010 – 2018Figure 18: Atopic Dermatitis Therapeutics Market, The UK, Revenue ($m), 2005 – 2010Figure 19: Atopic Dermatitis Therapeutics Market, The UK, Forecast ($m), 2010 – 2018Figure 20: Atopic Dermatitis Therapeutics Market, Japan, Revenue ($m), 2005 – 2010Figure 21: Atopic Dermatitis Therapeutics Market, Japan, Forecast ($m), 2010 – 2018Figure 22: Opportunity and Unmet Need in the Atopic Dermatitis Therapeutics Market, 2011Figure 23: Strategic Competitor Assessment of the Marketed Products in Atopic DermatitisTherapeutics, 2011Figure 24: Atopic Dermatitis Therapeutics, Clinical Pipeline by Mechanism of Action (%),2011Figure 25: Atopic Dermatitis – Clinical Pipeline by Phase of Development (%), 2011Figure 26: Technology Trends Analytics Framework, 2011Figure 27: Technology Trends Analytics Framework – Description, 2011Figure 28: Atopic Dermatitis, Global, Clinical Trials by Country, 2011Figure 29: Atopic Dermatitis, Global, Clinical Trials by Phase (%), 2011Figure 30: Atopic Dermatitis, Global, Clinical Trials by Status of Development (%), 2011Figure 31: Atopic Dermatitis, Global, Overall Sponsors (%), 2011Figure 32: Atopic Dermatitis, Global, Prominent Sponsors (%), 2011Figure 33: Atopic Dermatitis, Global, Top Companies by Phase, 2011Figure 34: Atopic Dermatitis Market, Drivers and Barriers, 2011Figure 35: Implications for Future Market Competition in the Atopic Dermatitis TherapeuticsMarket, 2011
    • Figure 36: Atopic Dermatitis Market, Clinical Pipeline by Company, 2011Figure 37: GlobalData Market Forecasting ModelLatest Market Research Reports: Rheumatoid Arthritis Therapeutics – Pipeline Assessment and Market Forecasts to 2018 Luxembourg Power Market Outlook to 2030 – Business Propensity Indicator ( BPI ) Market Trends Regulation and Competitive Landscape Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition Fats and Salad/Cooking Oils in the U.S.: Butter, Margarine, Olive Oil, and Beyond Cell Culture: The World Market for Media, Sera and Reagents, 3rd. EditionAbout Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: + 1 888 391 5441E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comVisit Our Blog: Market Research Reports